NEURONA THERAPEUTICS
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
NEURONA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-04-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.neuronatherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(650) 799-6465
Total Funding:
156.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag Google Maps US Privacy User Signal Mechanism
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Current Advisors List
Current Employees Featured
Founder
Investors List
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - Neurona Therapeutics
Sphera Funds Management
Sphera Funds Management investment in Venture Round - Neurona Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Neurona Therapeutics
The Column Group
The Column Group investment in Venture Round - Neurona Therapeutics
UCB Ventures
UCB Ventures investment in Venture Round - Neurona Therapeutics
Ironfire Ventures
Ironfire Ventures investment in Venture Round - Neurona Therapeutics
South Carolina Research Authority
South Carolina Research Authority investment in Grant - Neurona Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Neurona Therapeutics
The Column Group
The Column Group investment in Series A - Neurona Therapeutics
Alexsis de Raadt-St. James
Alexsis de Raadt-St. James investment in Series A - Neurona Therapeutics
Official Site Inspections
http://www.neuronatherapeutics.com Semrush global rank: 2.38 M Semrush visits lastest month: 7.75 K
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Neurona Therapeutics"
Neurona Therapeutics | NRTX-1001 Inhibitory Neuron โฆ
Chronic Disorders of the Nervous System are Prime Indications for Regenerative Medicine . Neurona is a clinical-stage biotherapeutics company developing regenerative cell therapies that permanently integrate into neural circuits, โฆSee details»
Neurona Therapeutics - Crunchbase Company Profile โฆ
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of โฆSee details»
Neurona Therapeutics - LinkedIn
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders.See details»
Neurona Therapeutics 2025 Company Profile: โฆ
Neurona Therapeutics General Information Description. Developer of regenerative cell therapies designed for the treatment of chronic neurological โฆSee details»
Neurona Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neurona Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โฆSee details»
Neurona Therapeutics Overview | SignalHire Company Profile
Organization Website: neuronatherapeutics.com : Social Links: Phone Number (650) 799-6465: Neurona Therapeutics industries Biotech: Headquarters Location: 170 Harbor Way, South San โฆSee details»
Neurona Therapeutics Raises
16 hours ago Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline โ The oversubscribed private โฆSee details»
A Conversation with CEO Cory Nicholas on Neurona โฆ
Aug 15, 2024 At the California Institute for Regenerative Medicine (CIRM), we enjoy highlighting achievements that come out of the research we support. We recently sat down with Cory Nicholas, PhD, CEO and Co-Founder of Neurona โฆSee details»
Neurona Therapeutics Inc. - VentureRadar
"Neurona Therapeutics is a cell therapy company driven by rigorous scientific discovery and focused on the development of breakthrough treatments for neurological disorders.See details»
Neurona Therapeutics - Craft
Neurona Therapeutics has 5 employees at their 1 location and $57.69 m in total funding,. See insights on Neurona Therapeutics including office locations, competitors, revenue, financials, โฆSee details»
Neurona Therapeutics Raises $102 Million to Fuel NRTX
4 hours ago - The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global โฆSee details»
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 โฆ
16 hours ago Neurona Therapeutics - The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus โฆSee details»
Neurona Therapeutics Company Overview, Contact Details
Neuronatherapeutics.com. SIC Code 8011 - Offices and Clinics of Doctors of Medicine. NAICS Code 541714 - Research and Development in Biotechnology (except Nanobiotechnology) โฆSee details»
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the ...
SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell the...See details»
Neurona Therapeutics - Overview, News & Similar companies
May 12, 2024 www.neuronatherapeutics.com. Revenue $12 Million. Industry Business Services . Most Recent Scoops. Jun 11 2024. New Hire. May 13 2024. Earnings. Neurona Therapeutics โฆSee details»
Neurona Therapeutics Raises $41.5M to Advance Neural Network ...
Jun 22, 2021 For more information about Neurona, visit www.neuronatherapeutics.com. About UCB Ventures. UCB Ventures is a โฌ150 million strategic corporate venture fund established in โฆSee details»
Neurona Therapeutics, Inc. (Neurona Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
โ SAFETY: NRTX-1001 has been well-tolerated to date at both high and low doses. No adverse events have been attributed to the cell therapy โ LOW DOSE COHORT: 92% median โฆSee details»
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001
4 hours ago - The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global โฆSee details»
Neurona raises $102m to advance cell therapy for drug-resistant ...
16 hours ago Mesial temporal lobe epilepsy is the most common form of epilepsy. Credit: PonyWang via Getty Images. Neurona Therapeutics has gained $102m to support the โฆSee details»
Neurona Therapeutics Raises $120M to Advance Groundbreaking โฆ
Feb 8, 2024 Neuronaโs investigational allogeneic, off-the-shelf, cell therapy candidates are designed to provide long-term repair of dysfunctional neural networks for multiple neurological โฆSee details»